Panacea Life Sciences Holdings Inc (PLSH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,015 | -9,143 | -4,782 | -5,232 | -10,225 |
| Depreciation Amortization | 1,751 | 2,798 | 1,855 | 1,692 | 1,604 |
| Accounts receivable | 431 | 38 | -97 | 152 | -107 |
| Accounts payable and accrued liabilities | N/A | N/A | 1,070 | 655 | 974 |
| Other Working Capital | 3,034 | 1,561 | 632 | -2,821 | -1,696 |
| Other Operating Activity | 1,275 | 2,345 | -2,599 | -2,093 | 3,704 |
| Operating Cash Flow | $-1,525 | $-2,400 | $-3,922 | $-7,647 | $-5,746 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 47 | 230 | N/A | N/A |
| PPE Investments | N/A | N/A | 446 | 120 | -541 |
| Net Acquisitions | -65 | -244 | -154 | -3,200 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | -1,500 |
| Investing Cash Flow | $-65 | $-197 | $523 | $-3,080 | $-2,041 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,091 | 4,090 | 3,303 | 5,984 | 962 |
| Debt Issued | N/A | N/A | 243 | 273 | N/A |
| Debt Repayment | -407 | -1,761 | -211 | -3,962 | -186 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 7,215 |
| Other Financing Activity | 0 | 254 | 0 | 0 | -187 |
| Financing Cash Flow | $1,684 | $2,584 | $3,335 | $2,296 | $7,804 |
| Beginning Cash Position | 7 | 20 | 84 | 8,516 | 2 |
| End Cash Position | 101 | 7 | 20 | 84 | 18 |
| Net Cash Flow | $94 | $-13 | $-65 | $-8,431 | $16 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,525 | -2,400 | -3,922 | -7,647 | -5,746 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -541 |
| Free Cash Flow | -1,525 | -2,400 | -3,922 | -7,647 | -6,288 |